Anti-BRG1 antibody [EPR3912],Abcam,AB108318
Anti-BRG1 antibody [EPR3912] (ab108318) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P, IP, and WB. Abcam's high quality manufacturing and validation processes ensure Anti-BRG1 antibody [EPR3912] (ab108318) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-BRG1 antibody [EPR3912] (ab108318) has been confirmed by Western Blot testing in BRG1 knockout HEK-293T cells ( ab263853 ). Anti-BRG1 antibody [EPR3912] (ab108318) specifically detects BRG1 (UniProt ID: P51532; Molecular weight: 185kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR3912 - ab222230 . Antibody clone EPR3912 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 647, Alexa Fluor ® 488, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor ® 594, Alexa Fluor ® 555, Alexa Fluor ® 568, Alexa Fluor ® 750 ( ab206598 , ab206712 , ab305626 , ab305627 , ab305628 , ab308772 , ab310487 , ab312016 , ab312493 , ab320893 ). Validated for CUT&RUN-seq, a key application to map protein-DNA interactions on a genome-wide scale using NGS. Highly specific BRG1 antibody, essential for researchers studying the SWI/SNF complex and chromatin remodeling. BRG1 is widely studied in the context of epigenetic regulation, BRG1 mutations, and cancer research. The BRM/BRG1-containing SWI/SNF complexes are recruited by transcription factors like p53 and BRCA1 to regulate gene activation, cell growth, and differentiation. BRM and BRG1 act as tumor suppressors, with their expression significantly reduced in various cancer cell lines. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Mouse, Rat, Human
Application
ICC/IF, IP, ChIC/CUT&RUN-seq, WB, IHC-P, Flow Cyt (Intra)
Platform ID
BAB357295296

Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Specifications
Scientific Background
Target data ATPase involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed : 15075294, PubMed : 29374058, PubMed : 30339381, PubMed : 32459350). Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP (By similarity). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1 (PubMed : 20418909). Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). In brown adipose tissue, involved in the regulation of thermogenic genes expression (By similarity). See full target information SMARCA4
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Please provide the required information below so that we can quickly source your products.
